The reversibility by dipyridamole of the increased sensitivity of in vivo platelet aggregation in rabbits after alloxan
- PMID: 1268037
- PMCID: PMC2041179
The reversibility by dipyridamole of the increased sensitivity of in vivo platelet aggregation in rabbits after alloxan
Abstract
Rabbits hyperglycaemic after previous intravenous injection with alloxan show an increased sensitivity of the aggregation of platelets to adenosine diphosphate applied topically to injured arteries. This increased sensitivity is completely reversed by treatment with oral dipyridamole but returns if the dipyridamole is withdrawn.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources